ValuEngine upgraded shares of Alcentra Capital (NASDAQ:ABDC) from a sell rating to a hold rating in a report released on Wednesday morning.

NASDAQ ABDC traded down $0.07 on Wednesday, hitting $6.50. 46,129 shares of the stock were exchanged, compared to its average volume of 79,452. Alcentra Capital has a fifty-two week low of $5.58 and a fifty-two week high of $9.01. The stock has a market capitalization of $89.89 million, a PE ratio of 4.92 and a beta of 0.59.

Alcentra Capital (NASDAQ:ABDC) last posted its quarterly earnings results on Monday, November 5th. The asset manager reported $0.22 EPS for the quarter, topping the consensus estimate of $0.21 by $0.01. Alcentra Capital had a negative net margin of 29.76% and a positive return on equity of 9.29%. The company had revenue of $6.55 million during the quarter, compared to analysts’ expectations of $6.61 million. Sell-side analysts predict that Alcentra Capital will post 0.96 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 3rd. Shareholders of record on Monday, December 31st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 11.08%. The ex-dividend date of this dividend is Friday, December 28th. Alcentra Capital’s dividend payout ratio (DPR) is presently 54.55%.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Belpointe Asset Management LLC acquired a new position in Alcentra Capital during the 2nd quarter worth approximately $107,000. Salzhauer Michael grew its holdings in Alcentra Capital by 100.8% during the 2nd quarter. Salzhauer Michael now owns 247,178 shares of the asset manager’s stock worth $910,000 after acquiring an additional 124,057 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Alcentra Capital by 17.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 629,022 shares of the asset manager’s stock worth $4,019,000 after acquiring an additional 94,111 shares in the last quarter. Institutional investors own 32.65% of the company’s stock.

Alcentra Capital Company Profile

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.

See Also: Outstanding Shares

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.